Single-dose oral challenges to validate eliciting doses in children with cow's milk allergy
Open Access
- 1 July 2021
- journal article
- research article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 32 (5), 1056-1065
- https://doi.org/10.1111/pai.13482
Abstract
Background There is increasing interest in the use of eliciting doses (EDs) to inform allergen risk management. The ED can be estimated from the distribution of threshold doses for allergic subjects undergoing food challenges within a specified population. Estimated ED05 values for cow's milk (the dose expected to cause objective allergic symptoms in 5% of the milk-allergic population) range from 0.5 mg to 13.9 mg cow's milk protein. We undertook a single-dose challenge study to validate a predicted ED05 for cow's milk of 0.5 mg protein. Methods Participants were recruited from 4 clinical centres. Predetermined criteria were used to identify patients reacting to 0.5 mg cow's milk protein (approximately 0.015 mL of fresh cow's milk). Children over 1 year underwent formal challenge to cow's milk to confirm clinical reactivity. Results 172 children (median age 6.0 (IQR 0.7-11) years, 57% male) were included in this analysis. Twelve (7.0%, 95% CI 3.7%-11.9%) children experienced objective symptoms that met the predetermined criteria. One participant had mild anaphylaxis that responded to a single dose of adrenaline, the remainder experienced only mild symptoms with no treatment required. We did not identify any baseline predictors of sensitization that were associated with objective reactivity to the single-dose challenge using 0.5 mg cow's milk protein. Conclusions These data support an estimated ED05 for cow's milk of 0.5 mg protein. Values for ED05 above 0.5 mg for cow's milk protein proposed for allergen risk management need to be reviewed.Funding Information
- Fundación de la Sociedad Española de Alergología e Inmunología Clínica
- NIHR Imperial Biomedical Research Centre
- FP7 Food, Agriculture and Fisheries, Biotechnology
- Medical Research Council
This publication has 27 references indexed in Scilit:
- Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergyJournal of Allergy and Clinical Immunology, 2014
- Allergen reference doses for precautionary labeling (VITAL 2.0): Clinical implicationsJournal of Allergy and Clinical Immunology, 2014
- Establishment of Reference Doses for residues of allergenic foods: Report of the VITAL Expert PanelFood and Chemical Toxicology, 2014
- Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology–European Academy of Allergy and Clinical Immunology PRACTALL consensus reportJournal of Allergy and Clinical Immunology, 2012
- International consensus on (ICON) pediatric asthmaAllergy, 2012
- Development of a standardized low‐dose double‐blind placebo‐controlled challenge vehicle for the EuroPrevall projectAllergy, 2011
- Anaphylaxis in Israel: Experience with 92 hospitalized childrenPediatric Allergy and Immunology, 2011
- Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposiumJournal of Allergy and Clinical Immunology, 2006
- Utility of food-specific IgE concentrations in predicting symptomatic food allergyJournal of Allergy and Clinical Immunology, 2001
- Specificity of allergen skin testing in predicting positive open food challenges to milk, egg and peanut in childrenClinical & Experimental Allergy, 2000